IO Biotech
NasdaqGS:IOBT
$ 0,02
+ $0,01 (100,00%)
0,02 $
+$0,01 (100,00%)
End-of-day quote: 04/08/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-1,35
Earnings Per Share
$0,00
Revenue Per Share
0,00%
Gross Margin %
$0,00 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-1,35
Revenue Per Share
$0,00
Gross Margin %
0,00%
Market Cap
$0,00 B
Long-Term Debt
$0,00 B

Financials

Year Year 2024 2023 2022 2021 2020
EPS Earnings Per Share $-1,45 $-1,98 $-2,48 $-17,30 $-82,36
Earnings Earnings $-95,53M $-130,44M $-0,00M $-0,00M $-0,00M
RPS Revenue Per Share $0,00 $0,00 N/A N/A N/A
Revenue Revenue $0,00M $0,00M $0,00M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $0,00M $-59,73M $-40,65M $0,00M
FCF Free Cash Flow $-82,39M $-72,06M $-60,42M $-40,80M $0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $-1,25 $-1,66 $-2,10 $-9,41 $-56,19
LT Debt Long-Term Debt N/A N/A N/A N/A N/A
Sha. Stocks 65,88M 65,88M 28,82M 28,82M 0M
×